<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1406222189
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CUREAML 500 mg Capsules
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HYDROXYCARBAMIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        52.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)	
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L01XX05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The name of your medicine is Cureaml. Each capsule contains hydroxyurea<strong> </strong>as the active ingredient. Hydroxyurea<strong> </strong>belongs to a group of medicines called anti-neoplastic medicines.</p><p>These medicines interfere with the growth of cancer cells.</p><p>Cureaml is used to treat some types of cancer such as cervical cancer and a type of leukaemia called chronic myeloid leukaemia (CML). The precise reason why you are being given Cureaml is best discussed with your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Cureaml:</strong></p><ul><li>If you are allergic to hydroxyurea or any of the other ingredients of this medicine (listed in section 6).</li><li>If you have history of any blood problems.</li><li>If you have severe anaemia.</li></ul><p><strong>Warnings and precautions</strong><br />Talk to your doctor or pharmacist before taking Cureaml.</p><p>If hemolytic anemia (disorder in which red blood cells are destroyed faster than they can be made) is detected when the blood tests are checked, your doctor will stop treatment with Cureaml.</p><p>Your doctor will do regular blood tests before and whilst you are taking Cureaml. You may need to control or treat the source conditions before starting treatment with Cureaml.</p><p><strong>Take special care with Cureaml if:</strong></p><ul><li>You have any kidney or liver problems</li><li>You are pregnant, planning to become pregnant or are breast feeding</li><li>You have ever suffered from gout</li><li>You have leg ulcers</li><li>You have previously received radiotherapy or chemotherapy, or are currently taking any other medicines for cancer treatment, especially interferon therapy</li><li>You have folic acid deficiency</li></ul><p>In long term use of hydroxyurea, secondary leukaemia has been reported. Skin cancer has also been reported in patient receiving long term hydroxyurea. You should protect your skin from the sun, regularly inspect your skin yourself and be screened by your doctor for secondary malignancies during routine follow-up visits.</p><p><strong>Other medicines and Cureaml</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, especially:</p><ul><li>Antiretroviral medicines (those that inhibit or destroy a retrovirus such as HIV), e.g., didanosine, stavudine and indinavir</li><li>Myelosuppressive medicines (including chemotherapies) and radiation therapy</li><li>Some vaccines, if you recently had a vaccination or are planning to have one, tell your doctor.</li></ul><p>Always tell your doctor about other medicines you may be taking or have recently taken including those obtained without a prescription as some medicines can affect each others actions.</p><p>It may be necessary to adjust the dose of some medicines if they are taken at the same time as Cureaml.</p><p><strong>Cureaml with alcohol</strong><br />You should check with your doctor before drinking alcohol to find out if it is advisable for you.</p><p><strong>Pregnancy, breast-feeding and fertility</strong><br />You should not take this medicine if you are pregnant, planning to become pregnant or are breastfeeding, unless your doctor recommends it.</p><p>When appropriate both male and female patients should discuss effective safe contraceptive measure before, during and for at least 12 months and 6 months respectively after treatment with Cureaml.</p><p>For male patients only, this medicine can affect the production of sperm so you might want to discuss the possibility of conservation (by storage of sperm) with your doctor.</p><p>In addition, if you are pregnant, planning to be or breastfeeding you should not handle the capsules.</p><p><strong>Driving and using machines</strong><br />You may feel drowsy. You should not drive or operate any machinery unless it has been shown not to affect you and have discussed it with your doctor.</p><p><strong>Cureaml<strong> </strong>contains lactose monohydrate and sodium</strong><br />Cureaml contains lactose monohydrate. Each hard capsule of Cureaml 500 mg Hard Capsules contains 41 mg lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p><p>Cureaml contains sodium. Each hard capsule of Cureaml 500 mg Hard Capsules contains 11.66 mg sodium. This medicine contains less than 1 mmol sodium (23 mg) per hard capsule, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor, physician experienced in antineoplastic agents or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>Cureaml is a cytotoxic drug. Caution is needed when handling Cureaml to minimize risk of exposure.</p><p>People who are not taking Cureaml should not be exposed to it.</p><p>You may be instructed to take your medicine on either a daily basis or an irregular basis.</p><p>The recommended dose is 20-30 mg of Cureaml per kg of your bodyweight once a day or 80 mg per kg of your body weight once every third day.</p><p>Elderly patients may be more sensitive to the effects of Cureaml and may be given a lower dose.</p><p>You can take this medicine at any time of the day, before or after meals. The capsules should be swallowed whole with a glass of water. However, if you find it difficult to swallow them, the contents of the capsule can be emptied into a glass of water and taken immediately. If some of the powder floats on the surface of the water, do not worry this is just filler from the capsule.</p><p>The capsules should be swallowed whole and should not be opened or crushed.</p><p>Do not inhale the contents of the capsules and if you spill any on the skin wipe it immediately.</p><p>While you are being treated with Cureaml it is important that you drink plenty of fluids. This will help your kidneys work well.</p><p>If you are going to have radiation therapy, this medicine will usually be started 7 days before starting radiation treatment.</p><p>You should keep taking your capsules until your doctor tells you to stop.</p><p><strong>Use in children</strong><br />There is limited experience with the use of hydroxyurea in this age group.</p><p><strong>If you take more </strong><strong>Cureaml than you should</strong><br />If you take too many capsules you should go to your nearest hospital Casualty Department immediately and take the medicine carton with you. The symptoms of overdose include; soreness, swelling of hands and feet and redness of skin.</p><p><strong>&nbsp;If you forget to take Cureaml</strong><br />If you forget to take a dose of this medicine do not take the missed dose at all. Take your next dose when it is due; do not take a double dose to make up for a forgotten dose.</p><p><strong>&nbsp;</strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>If you notice any of the following symptoms, you should stop taking the capsules and tell your doctor immediately as these may be signs of an allergic reaction: </strong></p><ul><li>Swelling of the face, lips, tongue or throat</li><li>Itching or skin rashes</li><li>Difficulty breathing</li><li>Unexplained fever, chills or sore throat</li><li>Wasting of muscles</li><li>Peeling of the skin and nails</li></ul><p>Tell your doctor immediately if you have a high fever (&gt;39&deg;C) with stomach, lung, muscle, liver, skin or heart problems within 6 weeks of taking Cureaml.</p><p>The following side effects have been seen in some people:<br /><strong>Very common: may affect more than 1 in 10 people </strong></p><ul><li>Blood disorders (reduction in white blood cells, red blood cells and platelets)</li><li>Lower back pain or pain in your side</li><li>Black tarry stools or blood in the stools</li><li>Unusual bleeding or bruising</li><li>Skin changes and muscle weakness (dermatomyositis)<ul><li>You may experience symptoms such as muscle tenderness, muscle weakness or tiredness (especially when climbing stairs, walking or rising from a chair etc), a rash on the face, hands or other parts of the body (which in some cases maybe scaly, purple and raised).</li></ul></li><li>Sores on the lips or mouth</li><li>Difficulty or pain passing urine</li><li>Absence or low amount of sperm in the semen (azoospermia or oligospermia).</li><li>Loss of appetite</li><li>Weakness, loss of energy</li><li>Sickness, diarrhoea, constipation, abdominal pain</li><li>Skin problems may occur including darkening of the skin, peeling of the skin, purple raised patches of skin and redness. There may be a worsening of existing redness or discomfort in the skin or mucous membranes if you have had radiation treatment in the past</li><li>Temporary hair loss</li><li>Kidney problems</li></ul><p><strong>Common: may affect up to 1 in 10 people: </strong></p><ul><li>Unexplained shortness of breath or cough with fever</li><li>Numbness or tingling of hands or feet</li><li>Skin cancer</li><li>Problems with the flow of the bile (cholestasis), the bile which is made by the liver to aid in digestion of food may not flow properly. A build up of bile can cause itchiness, yellow skin, very dark urine and very pale stools</li><li>Inflammation of the liver (hepatitis) which cause flu-like symptoms, including tiredness, loss of appetite, fever, aching, and feeling sick/being sick, pressure or pain below the right ribs and might also include yellowing of the skin or eyes</li><li>Drowsiness, dizziness, fits, confusion or hallucinations (seeing hearing or feeling things that are not there)</li><li>Headache</li></ul><p><strong>Rare: may affect up to 1 in 1000 people </strong></p><ul><li>Skin ulceration with severe infection</li><li>Tumour lysis syndrome (complications of substances released from treated cancer cells entering the blood)</li></ul><p><strong>Not known: frequency cannot be estimated from available data </strong></p><ul><li>Changes in the colour of the nails</li><li>Hemolytic anemia</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Store below 30&deg;C.</p><p>Store in the original package in order to protect from moisture.</p><p>Do not use this medicine after the expiry date which is stated on the carton after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice any visible signs of deterioration.</p><p>The capsule should not be opened, broken or crushed.</p><p>For medication administration, use gloves and wash hands thoroughly before and after. If gloves are not worn, tip tablets and from their container/blister pack directly into a disposable medicine cup.</p><p>Caution should be observed in handling, opened or crushed capsules. Avoid direct contact of the Cureaml with skin or mucous membranes. If such contact occurs, wash thoroughly with soap and water, rinse eyes thoroughly with sterile water, or plain water if sterile water is unavailable.</p><p>Pregnant should avoid handling Cureaml capsules.</p><p>Family members should use gloves when handling laundry or cleaning within or around toilets.</p><p>Close the lid before flushing the toilet and flush twice after each use by patient, for 48 hours after receiving chemotherapy. If available, use separate bathroom from family members.</p><p>Conduct double washing of linens and wash them separately from other family laundry.</p><p>Only keep the medicine if your doctor tells you to.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is hydroxyurea.</p><p>Each hard capsule of Cureaml 500 mg Hard Capsules contains 500 mg hydroxyurea.</p><p>The other ingredients are lactose monohydrate, citric acid, di-sodium hydrogen phosphate and magnesium stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Cureaml 500 mg Hard Capsules are hard gelatin polished capsules with light green cap and pink body, imprinted with black logo “HH3” for both cap and body, containing white powder free from visible contaminants in PVC/Aclar-aluminum blisters.

Pack size: 30 Hard capsules.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong><br />Jazeera Pharmaceutical Industries<br />Al-Kharj Road<br />P.O. Box 106229<br />Riyadh 11666, Saudi Arabia<br />Tel: + (966-11) 8107023, + (966-11) 2142472<br />Fax: + (966-11) 2078170<br />e-mail: SAPV@hikma.com</p><p><strong>Manufacturer</strong><br />The Arab Pharmaceutical Manufacturing PSC<br />Sahab<br />Industrial City<br />P.O. Box 41<br />Amman 11512, Jordan<br />Tel: + (962-6) 4023916<br />Fax: + (962-6) 4023917</p><p><strong>Reporting of side effects</strong><br />If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can also help provide more information on the safety of this medicine.</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                 This leaflet was last revised in 10/2023; version number SA5.0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">اسم دوائك هو كيورمل. تحتوي كل كبسولة على المادة الفعالة هيدروكسي يوريا. ينتمي هيدروكسي يوريا إلى مجموعة من الأدوية التي تسمى الأدوية المضادة للأورام.</p><p dir="RTL">هذه الأدوية تتدخل بنمو الخلايا السرطانية.</p><p dir="RTL">يستخدم كيورمل لعلاج بعض أنواع السرطان مثل سرطان عنق الرحم، ونوع من أنواع سرطان الدم يسمى ابيضاض الدم النقوي المزمن. من الأفضل أن تناقش مع طبيبك السبب المحدد لإعطائك كيورمل.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول كيورمل:</strong></p><ul dir="rtl"><li>إذا كنت تعاني من حساسية لهيدروكسي يوريا أو لأي من المواد الأخرى المستخدمة في تركيبة هذا الدواء (المذكورة في القسم 6).</li><li>إذا كان لديك تاريخ مرضي من مشاكل الدم.</li><li>إذا كنت تعاني من فقر دم شديد.</li></ul><p dir="RTL"><strong>الاحتياطات والتحذيرات&nbsp;</strong><br />تحدث مع طبيبك أو الصيدلي قبل تناول كيورمل.</p><p dir="RTL">إذا تم اكتشاف فقر الدم الانحلالي (اضطراب يحدث فيه تحطم لخلايا الدم الحمراء بسرعة أكبر من تكونها) عند التحقق من فحوصات الدم، سيقوم طبيبك بإيقاف العلاج بكيورمل.</p><p dir="RTL">سيجري لك طبيبك فحوصات دم دورية قبل وأثناء تناولك كيورمل. قد تكون بحاجة إلى التحكم او علاج الحالة الرئيسية قبل تناول كيورمل.</p><p dir="RTL"><strong>اتبع عناية خاصة عند تناول كيورمل إذا:</strong></p><ul dir="rtl"><li>كنت تعاني من أي مشاكل في الكلى أو الكبد</li><li>كنت حاملا، تخططين للحمل أو إذا كنت مرضعة</li><li>كنت قد عانيت مسبقاً من مرض النقرس</li><li>كنت تعاني من تقرحات في القدم</li><li>خضعت سابقاً للعلاج الإشعاعي أو الكيميائي، أو تتناول حالياً أدوية أخرى لعلاج السرطان وخاصة علاج الانترفيرون</li><li>كنت تعاني من نقص حمض الفوليك</li></ul><p dir="RTL">تم الإبلاغ عن حالات ابيضاض الدم الثانوي عند استخدام هيدروكسي يوريا على المدى الطويل. تم الابلاغ عن سرطان الجلد عند المرضى الذين يستخدمون هيدروكسي يوريا على المدى الطويل. يجب أن تحمي جلدك من أشعة الشمس وأن تتفقد جلدك بنفسك بشكل منتظم ويتم فحص الورم الخبيث الثانوي من قبل طبيبك خلال زيارات المتابعة الروتينية.</p><p dir="RTL"><strong>الأدوية الأخرى وكيورمل&nbsp;</strong><br />أخبر طبيبك أو الصيدلي إذا كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى، خاصة:</p><ul dir="rtl"><li>الأدوية المضادة للفيروسات القَهْقَرِية (الأدوية التي تثبط أو تحطم الفيروس القهقري مثل فيروس العوز المناعي البشري)، مثل ديدانوسين، ستافودين واندينافير</li><li>الأدوية الكابتة للنقي (والتي تشمل العلاج الكيميائي) والعلاج بالأشعة</li><li>بعض المطاعيم، أخبر طبيبك إذا أخذت مطعوم مؤخراً أو تخطط لأخذ مطعوم.</li></ul><p dir="RTL">أخبر طبيبك دائماً عن الأدوية الاخرى التي قد تتناولها أو تناولتها مؤخراً ويشمل ذلك تلك التي حصلت عليها بدون وصفة لأنه قد تؤثر بعض الأدوية في طريقة عمل بعضها.</p><p dir="RTL">قد يلزم تعديل جرعة بعض الأدوية إذا تم تناولها في الوقت نفسه مع كيورمل. &nbsp;</p><p dir="RTL"><strong>كيورمل مع الكحول&nbsp;</strong><br />يجب عليك استشارة طبيبك قبل شرب الكحول لمعرفة ما إن كان ينصح به لك.</p><p dir="RTL"><strong>&nbsp;الحمل</strong><strong>،<strong> </strong>الرضاعة والخصوبة&nbsp;</strong><br />يجب ألا تستخدمي هذا الدواء إذا كنت حاملاً، تخططين لذلك أو مرضعة إلا إذا أوصى به طبيبك.</p><p dir="RTL">يجب أن يناقش المرضى سواء رجال أو نساء وسائل منع الحمل الآمنة الفعالة قبل وخلال العلاج ولمدة 12 شهر و6 شهور على الأقل على التوالي بعد العلاج بكيورمل.</p><p dir="RTL">بالنسبة للمرضى الرجال فقط، من الممكن أن يؤثر هذا الدواء على إنتاج الحيوانات المنوية، لذلك من الممكن أن ترغب في مناقشة إمكانية الإحتفاظ (تخزين الحيوانات المنوية) مع طبيبك.</p><p dir="RTL">بالإضافة إلى ذلك، إذا كنت حاملاً، تخططين لذلك أو مرضعة، يجب ألا تتعاملي مع الكبسولات.</p><p dir="RTL"><strong>&nbsp;القيادة واستخدام الآلات&nbsp;</strong><br />قد تشعر بالنعاس. يجب ألا تقود أو تشغل الآلات إلا إذا كان من الواضح أنه لا يؤثر عليك وبعد استشارة طبيبك.</p><p dir="RTL"><strong>يحتوي كيورمل على اللاكتوز<strong> </strong>أحادي الماء والصوديوم&nbsp;</strong><br />يحتوي كيورمل على اللاكتوز أحادي الماء. تحتوي كل كبسولة صلبة من كيورمل 500 ملغم كبسولات صلبة على 41 ملغم لاكتوز أحادي الماء. إذا أخبرك طبيبك بأنك تعاني من عدم تحمل لبعض أنواع السكريات، فتواصل مع طبيبك قبل تناول هذا المستحضر الدوائي.</p><p dir="RTL">يحتوي كيورمل على الصوديوم.<strong> </strong>تحتوي كل كبسولة صلبة من كيورمل 500 ملغم كبسولات صلبة على 11,66 ملغم صوديوم. يحتوي هذا الدواء على أقل من 1 ملمول صوديوم (23 ملغم) لكل كبسولة صلبة، وبذلك يعتبر &rsquo;خالٍ من الصوديوم&lsquo; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول هذا الدواء دائماً تماماً كما أخبرك طبيبك، أخصائي مضادات الأورام أو الصيدلي. استشر طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL">كيورمل هو دواء سام للخلايا. الحذر مطلوب عند التعامل مع كيورمل لتقليل خطر التعرض له.</p><p dir="RTL">يجب على الأشخاص الذين لا يتناولون كيورمل عدم التعرض له.</p><p dir="RTL">قد تعطى تعليمات لاستعمال الدواء إما بشكل يومي أو بشكل غير منتظم.</p><p dir="RTL">الجرعة الموصى بها هي 20-30 ملغم من كيورمل لكل كغم من وزنك مرة واحدة يومياً أو 80 ملغم لكل كغم من وزنك مرة كل ثلاثة أيام.</p><p dir="RTL">المرضى كبار السن قد يكونوا حساسين بشكل أكثر لتأثير كيورمل وقد يتم إعطائهم جرعة أقل.</p><p dir="RTL">تستطيع تناول هذا الدواء في أي وقت من اليوم، قبل أو بعد الوجبات. يجب بلع الكبسولات كاملة مع كأس من الماء. على أية حال، إذا وجدت صعوبة في بلع الكبسولات، تستطيع أن تفرغ محتويات الكبسولة في كأس من الماء وتأخذها فوراً. إذا طفى جزء من المسحوق على سطح الماء، فلا تقلق هذا فقط من المواد المضافة للكبسولات.</p><p dir="RTL">يجب بلع الكبسولات كاملة وعدم فتحها أو طحنها.</p><p dir="RTL">لا تقم باستنشاق محتوى الكبسولات وإذا قمت بسكب أي كمية على الجلد فقم بمسحها على الفور.</p><p dir="RTL">من المهم أن تشرب كمية كافية من السوائل خلال فترة علاجك بكيورمل. هذا سيساعد الكلى لديك أن تعمل جيداً.</p><p dir="RTL">إذا كنت ستخضع للعلاج بالأشعة، فعادة ما يتم البدء بهذا الدواء سبعة أيام قبل البدء بالعلاج بالأشعة.</p><p dir="RTL">يجب أن تستمر بتناول الكبسولات حتى يبلغك طبيبك بالتوقف.</p><p dir="RTL"><strong>الاستخدام في الأطفال&nbsp;</strong><br />يوجد تجارب محدودة لاستخدام هيدروكسي يوريا لدى هذه الفئة العمرية.</p><p dir="RTL"><strong>إذا تناولت كيورمل أكثر من اللازم&nbsp;</strong><br />إذا تناولت الكثير من الكبسولات يجب أن تذهب إلى قسم طوارئ في أقرب مستشفى لديك على الفور وأن تأخذ معك علبة الدواء. أعراض الجرعة الزائدة تشمل: التقرح، تورم اليدين والقدمين واحمرار الجلد.</p><p dir="RTL"><strong>إذا نسيت تناول كيورمل&nbsp;</strong><br />إذا نسيت تناول جرعة من هذا الدواء، لا تتناول الجرعة المنسية أبداً. تناول الجرعة اللاحقة في موعدها، لا تضاعف الجرعة لتعوض الجرعة المنسية.</p><p dir="RTL">للاستفسار أو المزيد من المعلومات عن استخدام هذا الدواء، يرجى استشارة طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثاراً جانبيةً، إلا أنه ليس بالضرورة أن تحدث لدى الجميع.</p><p dir="RTL"><strong>إذا لاحظت أي من الأعراض التالية، يجب عليك التوقف عن تناول الكبسولات وإخبار طبيبك على الفور لأن ذلك من الممكن أن يكون نتيجة رد فعل تحسسي:</strong></p><ul dir="rtl"><li>تورم في الوجه، الشفتين، اللسان أو الحلق</li><li>حكة أو طفح جلدي</li><li>صعوبات في التنفس</li><li>حمى غير مفسرة، قشعريرة أو التهاب الحلق</li><li>فقدان في العضلات</li><li>تقشر الجلد والأظافر</li></ul><p dir="RTL">أخبر طبيبك على الفور إذا عانيت من حمى مرتفعة (&gt;39&deg; مئوية) مع مشاكل في المعدة، الرئة، العضلات، الكبد، الجلد أو القلب خلال 6 أسابيع من تناول كيورمل.</p><p dir="RTL">تم ملاحظة الآثار الجانبية التالية لدى بعض الأشخاص:&nbsp;<br /><strong>شائعة جدًا: قد تؤثر في أكثر من شخص من بين كل 10 أشخاص</strong></p><ul dir="rtl"><li>اضطرابات في الدم (انخفاض في عدد الخلايا البيضاء، خلايا الدم الحمراء، والصفائح الدموية)</li><li>ألم في أسفل الظهر أو في الجانب</li><li>براز أسود قطراني أو دم في البراز</li><li>نزيف أو تكدّم غير اعتيادي</li><li>تغيرات في الجلد وضعف بالعضلات (التهاب العضلات والجلد)<ul><li>قد تواجه أعراض مثل الإيلام العضلي، الضعف العضلي أو التعب (خاصة عند صعود الدرج، المشي أو القيام عن الكرسي الخ)، طفح على الوجه، اليدين أو أجزاء أخرى من الجسم (والذي قد يكون أحياناً متقشر، أرجواني وناتئ)</li></ul></li><li>تقرحات على الوجه والشفتين</li><li>صعوبة أو ألم عند التبول</li><li>فقدان أو وجود كميات قليلة من الحيوانات المنوية في السائل المنوي (فقد النطاف أو قلة النطاف)</li><li>فقدان الشهية</li><li>ضعف، فقدان للطاقة</li><li>المرض، الإسهال، الإمساك، ألم البطن</li><li>من الممكن حدوث مشاكل جلدية وتشمل اغمقاق الجلد، تقشر الجلد، بقع جلدية أرجوانية بارزة واحمرار. إذا كنت قد خضعت سابقا للعلاج الإشعاعي من الممكن أن يكون ذلك احمرار موجود وأصبح أكثر سوءاً أو عدم ارتياح للجلد أو الغشاء المخاطي</li><li>فقدان مؤقت للشعر</li><li>مشاكل في الكلى</li></ul><p dir="RTL"><strong>شائعة: قد تؤثر فيما يصل إلى شخص من بين كل 10 أشخاص</strong></p><ul dir="rtl"><li>ضيق في النفس أو سعال مع حمى غير مفسّر</li><li>خدران أو تنميل في اليدين أو القدمين</li><li>سرطان في الجلد</li><li>مشاكل في تدفق الصفراء (الركود الصفراوي)، الصفراء التي تصنع في الكبد والتي تساعد في عملية هضم الطعام قد لا تتدفق بطريقة مناسبة. تراكم الصفراء قد يسبب الحكة، اصفرار الجلد، اغمقاق البول والبهتان الشديد في لون البراز</li><li>التهاب الكبد والذي قد يسبب آثار جانبية مشابهة للإنفلونزا والتي تشمل التعب، فقدان الشهية، الحمى، الألم، الغثيان/القيء، ضغط أو ألم تحت الجزء الأيمن من القفص الصدري والتي تشمل أيضا اصفرار الجلد أو العينين</li><li>النعاس، الدوخة، النوبات، الارتباك أو الهلوسة (رؤية، سماع أو الإحساس بأشياء غير موجودة)</li><li>الصداع</li></ul><p dir="RTL"><strong>نادرة: قد تؤثر فيما يصل إلى شخص من بين كل 1000 شخص</strong></p><ul dir="rtl"><li>تقرحات جلدية مصاحب لالتهابات حادة</li><li>متلازمة انحلال&nbsp;الورم (مضاعفات لانطلاق مواد من الخلايا السرطانية التي تم علاجها إلى الدم)</li></ul><p dir="RTL"><strong>غير معروف: لا يمكن تقدير التكرار من البيانات المتاحة</strong></p><ul dir="rtl"><li>تغير في لون الأظافر</li><li>فقر الدم الانحلالي</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.</p><p dir="RTL">يحفظ عند درجة حرارة أقل من 30&deg; مئوية.</p><p dir="RTL">يحفظ داخل العبوة الأصلية للحماية من الرطوبة.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية بعد &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت أي علامات تلف واضحة عليه.</p><p dir="RTL">يجب عدم فتح، كسر أو طحن الكبسولات.</p><p dir="RTL">قم باستخدام القفازات وغسل اليدين جيداً قبل وبعد الاستعمال الطبي. في حال عدم ارتداء القفازات، أفرغ الأقراص من العبوة/ الشريط بشكل مباشر داخل كوب مخصص للدواء للاستعمال لمرة واحدة.</p><p dir="RTL">يجب توخي الحذر عند التعامل مع الكبسولات المفتوحة أو المطحونة. تجنب التعرض المباشر لكيورمل مع الجلد أو الغشاء المخاطي. وفي حال حدوث ذلك، أغسله جيداً في الصابون والماء، وقم بغسل العينين جيداً بالماء المعقم، أو الماء العادي في حال كان الماء المعقم غير متوفر.</p><p dir="RTL">يجب على الحامل تجنب التعرض لكبسولات كيورمل.</p><p dir="RTL">يجب على أفراد العائلة ارتداء القفازات عند التعامل مع الغسيل أو تنظيف المراحيض أو ما حولها.</p><p dir="RTL">قم بإغلاق الغطاء قبل شطف المرحاض وقم بشطف المرحاض مرتين بعد كل استعمال للمريض، ولمدة 48 ساعة بعد تناول العلاج الكيميائي. قم باستخدام مرحاض منفصل عن باقي أفراد العائلة، إذا كان ذلك ممكناً.</p><p dir="RTL">قم بغسل الأغطية والملابس مرتين واغسلهم بشكل منفصل عن غسيل العائلة.</p><p dir="RTL">احتفظ بهذا الدواء فقط إذا طلب منك الطبيب ذلك.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه الإجراءات ستساعد في الحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي هيدروكسي يوريا.</p><p dir="RTL">&nbsp;تحتوي كل كبسولة صلبة من كيورمل 500 ملغم كبسولات صلبة على 500 ملغم هيدروكسي يوريا.</p><p dir="RTL">المواد الأخرى المستخدمة في التركيبة التصنيعية هي لاكتوز أحادي الماء، حمض السيتريك، فوسفات هيدروجين ثنائي الصوديوم وستيرات المغنيسيوم.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كيورمل 500 ملغم كبسولات صلبة هي كبسولات جيلاتينية صلبة مصقولة ذات غطاء أخضر فاتح وجسم وردي، مطبوع عليها رمز &quot;HH3&quot; باللون الأسود على كل من الغطاء والجسم، تحتوي على مسحوق ابيض خالٍ من الملوثات المرئية في أشرطة من كلوريد متعدد الڤينيل/أكلار-الألومنيوم.</p><p dir="RTL">حجم العبوة: 30 كبسولة صلبة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك رخصة التسويق&nbsp;</strong><br />شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666، المملكة العربية السعودية<br />هاتف: 8107023 (11-966) +، 2142472 (11-966) +<br />فاكس: 2078170 (11-966) +<br />البريد الإلكتروني: SAPV@hikma.com</p><p dir="RTL"><strong>الشركة المصنعة&nbsp;</strong><br />الشركة العربية لصناعة الأدوية المساهمة الخاصة&nbsp;<br />سحاب<br />المدينة الصناعية<br />صندوق بريد 41<br />عمان 11512، الأردن<br />هاتف: 4023916(6-962) +<br />فاكس: 4023917 (6-962) +</p><p dir="RTL"><strong>للإبلاغ عن الآثار الجانبية&nbsp;</strong><br />تحدث إلى الطبيب، الصيدلي، أو الممرض إذا عانيت من أية آثار جانبية، وذلك يشمل أي آثار الجانبية لم يتم ذكرها في هذه النشرة. كما أنه يمكنك الإبلاغ عن هذه الآثار مباشرةً (انظر التفاصيل المذكورة أدناه) من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة بتوفير معلومات مهمة عن سلامة الدواء.</p><ul dir="rtl"><li>المملكة العربية السعودية</li></ul><p dir="RTL">المركز الوطني للتيقظ الدوائي&nbsp;<br />مركز الاتصال الموحد: 19999&nbsp;<br />البريد الإلكتروني: npc.drug@sfda.gov.sa&nbsp;<br />الموقع الإلكتروني: &nbsp;https://ade.sfda.gov.sa</p><ul dir="rtl"><li>دول الخليج العربي الأخرى</li></ul><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             تمت مراجعة هذه النشرة بتاريخ 10/2023؛ رقم النسخة SA5.0.


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cureaml 500 mg Hard Capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each hard capsule of Cureaml 500 mg Hard Capsules contains 500 mg hydroxyurea.

Excipient with known effect: Lactose monohydrate and sodium. 

Each capsule contains 41 mg lactose monohydrate.

Each capsule contains 11.66 mg sodium. 

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hard Capsules.

Cureaml 500 mg Hard Capsules are hard gelatin polished capsules with light green cap and pink body, imprinted with black logo “HH3” for both cap and body, containing white powder free from visible contaminants.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The treatment of chronic myeloid leukaemia.</p><p>The treatment of cancer of the cervix in conjunction with radiotherapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>CUREAML&nbsp;treatment must be initiated and monitored under the supervision of a physician experienced in antineoplastic agents.</p><p><strong>Posology</strong><br /><u>Adults</u><br />Treatment regimens can be continuous or intermittent. The continuous regimen is particularly suitable for chronic myeloid leukaemia, while the intermittent regimen, with its diminished effect on the bone marrow, is more satisfactory for the management of cancer of the cervix.</p><p>Cureaml should be started 7 days before concurrent irradiation therapy. If Cureaml is used concomitantly with radiotherapy, adjustment of radiation dosage is not usually necessary.</p><p>An adequate trial period for determining the antineoplastic effect of hydroxyurea is six weeks. Where there is a significant clinical response therapy may be continued indefinitely, provided that the patient is kept under adequate observation and shows no unusual or severe reactions. Therapy should be interrupted if the white cell count drops below 2.5x10<sup>9 </sup>L or the platelet count below 100x10<sup>9</sup>/L (see section 4.4).</p><p>In these cases, the counts should be reevaluated after three days and therapy resumed when the counts return to acceptable levels. Hematopoietic rebound is usually rapid. If rapid rebound has not occurred during combined hydroxyurea and irradiation therapy, irradiation may also be interrupted. Anemia, even if severe, can be managed without interrupting hydroxyurea therapy.</p><p>Severe gastric distress, such as nausea, vomiting, and anorexia, resulting from combined therapy may usually be controlled by interruption of Cureaml administration.</p><p>Pain or discomfort from inflammation of the mucous membranes at the irradiated site (mucositis) is usually controlled by measures such as topical anesthetics and orally administered analgesics. If the reaction is severe, Cureaml therapy may be temporarily interrupted; if it is extremely severe, irradiation dosage may, in addition, be temporarily postponed.</p><p><em>Continuous therapy</em><br />Cureaml 20-30 mg/kg should be given daily in single doses. Dosage should be based on the patient&#39;s actual or ideal weight, whichever is the less. Therapy should be monitored by repeat blood counts.</p><p><em>Intermittent therapy</em><br />Cureaml 80 mg/kg in single doses should be given every third day. Using the intermittent regimes the likelihood of WBC depression is diminished, but if low counts are produced, 1 or more doses of Cureaml should be omitted.</p><p>Concurrent use of Cureaml with other myelosuppressive agents may require adjustments of dosages.</p><p><u>Special Populations</u><br /><em>Children</em><br />Because of the rarity of these conditions in children, dosage regimens have not been established.</p><p><em>Elderly</em><br />Elderly patients may be more sensitive to the effects of hydroxyurea, and may require a lower dosage regimen.</p><p><em>Renal Impairment</em><br />Since renal excretion is a pathway of elimination, consideration should be given to decreasing the dosage of Cureaml in this population.</p><p><strong>Method of administration</strong><br />For oral use.</p><p>NB: If the patient prefers, or is unable to swallow capsules, the contents of the capsules may be emptied into a glass of water and taken immediately. The contents of capsules should not be inhaled or allowed to come into contact with the skin or mucous membranes. Spillages must be wiped immediately.</p><p>CUREAML&nbsp;is a cytotoxic medication. Follow applicable special handling and disposal procedures (see section 6.6).</p><p>Capsules should be swallowed whole.</p><p>The capsules should not be broken or crushed, if possible. This might produce powder that can contaminate workplace surfaces.</p><p>If capsules must be opened or crushed, this should be done by a professional trained personal experienced in safe handling of cytotoxic drugs using an appropriate equipment and safety procedures.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Marked leucopenia (<2.5wbcx10*9/L), thrombocytopenia (< 100x10*9/L), or severe anaemia.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Bone Marrow</em><br />The complete status of the blood, including bone marrow examination, if indicated, as well as kidney function and liver function should be determined prior to, and repeatedly during, treatment. If bone marrow function is depressed, treatment with Cureaml should not be initiated. The determination of haemoglobin level, total leukocyte counts, and platelet counts should be performed at least once a week throughout the course of hydroxyurea therapy. If WBC falls below 2.5x10<sup>9</sup>/L or platelet count to &lt;100x10<sup>9</sup>/L, therapy should be interrupted. Counts should be rechecked after 3 days and treatment resumed when they rise significantly towards normal.</p><p>Hydroxyurea may produce bone marrow suppression; leukopenia is generally its first and most common manifestation. Thrombocytopenia and anaemia occur less often and are seldom seen without a preceding leukopenia. Bone marrow depression is more likely in patients who have previously received radiotherapy or cytotoxic cancer chemotherapeutic agents; hydroxyurea should be used cautiously in such patients. The recovery from myelosuppression is rapid when hydroxyurea therapy is interrupted.</p><p><em>Anaemia</em><br />Severe anaemia must be corrected with whole blood replacement before initiating therapy with hydroxyurea. If, during treatment, anaemia occurs, correct without interrupting hydroxyurea therapy. Erythrocytic abnormalities; megaloblastic erythropoeisis, which is self-limiting, is often seen early in the course of hydroxyurea therapy. The morphologic change resembles pernicious anaemia, but is not related to vitamin B<sub>12</sub>&nbsp;or folic acid deficiency. The macrocytosis may mask the incidental development of folic acid deficiency; regular determinations of serum folic acid are recommended. Hydroxyurea may also delay plasma iron clearance and reduce the rate of iron utilisation by erythrocytes but it does not appear to alter the red blood cell survival time.</p><p><em>Irradiation</em><br />Patients who have received irradiation therapy in the past may have an exacerbation of postirradiation erythema when Cureaml is given.</p><p><em>Renal</em><br />Hydroxyurea should be used with caution in patients with marked renal dysfunction.</p><p><em>HIV</em><br />Hydroxyurea is not licensed for use in combination with antiretroviral agents for HIV disease and it may cause treatment failure and toxicities (in some cases fatal) in HIV patients (see section 4.5).</p><p><em>Cancer</em><br />In patients receiving long-term therapy with hydroxyurea for myeloproliferative disorders, such as polycythemia vera and thrombocythemia, secondary leukaemia has been reported. It is unknown whether this leukaemogenic effect is secondary to hydroxyurea or associated with the patient&#39;s underlying disease. Skin cancer has also been reported in patients receiving long-term hydroxyurea. Patients should be advised to protect skin from sun exposure. conduct self-inspection of the skin and be screened for secondary malignancies during routine follow-up visits.</p><p><em>Vasculitis toxicities</em><br />Cutaneous vasculitic toxicities including vasculitic ulcerations and gangrene have occurred in patients with myeloproliferative disorders during therapy with hydroxyurea. The risk of vasculitic toxicities is increased in patients who receive prior or concomitant interferon therapy. The digital distribution of these vasculitic ulcerations and progressive clinical behaviour of peripheral vasculitic insufficiency leading to digital infarct or gangrene were distinctly different than the typical skin ulcers generally described with hydroxyurea. Due to potentially severe clinical outcomes for the cutaneous vasculitic ulcers reported in patients with myeloproliferative disease, hydroxyurea should be discontinued if cutaneous vasculitic ulcerations develop and alternative cytoreductive agents should be initiated as indicated.</p><p><em>Uric acid</em><br />The possibility of an increase in serum uric acid, resulting in the development of gout or, at worst, uric acid nephropathy, should be borne in mind in patients treated with hydroxyurea, especially when used with other cytotoxic agents. It is therefore important to monitor uric acid levels regularly and maintain a high fluid intake during treatment.</p><p><em>Vaccinations</em><br />Concomitant use of Cureaml with a live virus vaccine may potentiate the replication of the vaccine virus and/or may increase some of the adverse reactions of the vaccine virus because normal defence mechanisms may be suppressed by hydroxyurea. Vaccination with a live vaccine in a patient taking Cureaml may result in severe infection. The patient&#39;s antibody response to vaccines may be decreased. The use of live vaccines should be avoided during treatment and for at least six months after treatment has finished and individual specialist advice sought (see section 4.5).</p><p><strong>Cureaml Contains sodium and Lactose</strong><br />Each hard capsule of Cureaml 500 mg Hard Capsules contains 11.66 mg sodium which is less than 23 mg, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p>Cureaml contains lactose monohydrate. Each hard capsule of Cureaml 500 mg Hard Capsules contains 41 mg lactose monohydrate. This product contains lactose, patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The myelosuppressive activity may be potentiated by previous or concomitant radiotherapy or cytotoxic therapy. Fatal and non-fatal pancreatitis has occurred in HIV-infected patients during therapy with hydroxyurea and didanosine, with or without stavudine. Hepatotoxicity and hepatic failure resulting in death were reported during post-marketing surveillance in HIV-infected patients treated with hydroxyurea and other antiretroviral agents. Fatal hepatic events were reported most often in patients treated with the combination of hydroxyurea, didanosine and stavudine. This combination should be avoided. Peripheral neuropathy, which was severe in some cases, has been reported in HIV-infected patients receiving hydroxyurea in combination with antiretroviral agents, including didanosine, with or without stavudine. (see section 4.4).</p><p>Studies have shown that there is an analytical interference of hydroxyurea with the enzymes (urease, uricase, and lactic dehydrogenase) used in the determination of urea, uric acid and lactic acid, rendering falsely elevated results of these in patients treated with hydroxyurea.</p><p><u>Vaccinations</u><br />There is an increased risk of severe or fatal infections with the concomitant use of live vaccines. Live vaccines are not recommended in immunosuppressed patients (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Drugs which affect DNA synthesis, such as hydroxyurea, may be potent mutagenic agents. The physician should carefully consider this possibility before administering this drug to male or female patients who may contemplate conception. Since hydroxyurea is a cytotoxic agent it has produced a teratogenic effect in some animal species.</p><p>In rats and dogs, high doses of hydroxyurea reduced sperm production.</p><p>Hydroxyurea is excreted in human breast milk. Because of the potential for serious adverse reactions in nursing infants from hydroxyurea, a decision should be made whether to discontinue nursing or to discontinue hydroxyurea, taking into account the importance of the drug to the mother.</p><p>Cureaml can cause fetal harm when administered to a pregnant woman. Cureaml should not normally be administered to patients who are pregnant, or to mothers who are breast feeding, unless the potential benefits outweigh the possible hazards.</p><p>Female patients of reproductive potential should be counselled to use effective contraception during therapy and for at least 6months after therapy.</p><p>Azoo- or oligospermia, sometimes reversible, have been observed in men. Male patient should be informed about the possibility of sperm conservation before the start of therapy. hydroxyurea may be genotoxic.</p><p>Men under therapy are advised to use effective contraceptive measures during and at least 1 year after therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydroxyurea may cause drowsiness. Patients receiving it should not drive or operate machinery unless it has been shown not to affect physical or mental ability.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bone-marrow suppression is the major toxic effect of hydroxyurea.</p><p>Cutaneous vasculitic toxicities including vasculitic ulcerations and gangrene have occurred in patients with myeloproliferative disorders during therapy with hydroxyurea. The risk of vasculitic toxicities is increased in patients who receive prior or concomitant interferon therapy.</p><p>In some patients, hyperpigmentation, nail pigmentation, atrophy of skin and nails, scaling, violet papules and alopecia have been observed following several years of long-term daily maintenance therapy with hydroxyurea.</p><p>Cases of fatal and non-fatal pancreatitis and hepatotoxicity and severe peripheral neuropathy have been observed in HIV patients when hydroxyurea was administered with antiretroviral agents, in particular didanosine plus stavudine. Patients treated with hydroxyurea in combination with didanosine, stavudine and indinavir showed a median decline in CD4 cells of approximately 100/mm<sup>3</sup>&nbsp;(see sections 4.4 and 4.5).</p><p>Adverse reactions observed with combined hydroxyurea and irradiation therapy were similar to those reported with the use of hydroxyurea alone, primarily bone marrow depression (leukopenia and anaemia) and gastric irritation. Nearly all patients receiving an adequate course of combined hydroxyurea and irradiation therapy will develop leukopenia. Decreased platelet counts (&lt;100,000/mm<sup>3</sup>) have occurred rarely and usually in the presence of marked leukopenia. hydroxyurea may potentiate some adverse reactions usually seen with irradiation alone, such as gastric distress and mucositis.</p><p><em>Hypersensitivity</em><br />Drug induced fever<br />High fever (&gt;39&deg;C) requiring hospitalisation in some cases has been reported concurrently with gastrointestinal, pulmonary, muscloskeletal, hepatobiliary, dermatoloigical or cardiovascular manifestations. Onset typically occurred within 6 weeks of initiation and resolved promptly after discontinuation of hydroxyurea. Upon readministration fever re-occurred within 24 hours.</p><p>The list is presented by system organ class, MedDRA preferred term, and frequency using the following frequency categories: very common (&ge;1/10), common (&ge;1/100, &lt; 1/10), uncommon (&ge;1/1000, &lt;1/100), rare (&ge;1/10000, &lt;1/1000), very rare (&lt; 1/10000), and not known (cannot be estimated from the available data).</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>MedDRA Term</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and Infestations</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Gangrene</p></td></tr><tr><td style="vertical-align:top"><p>Neoplasms Benign and Malignant (including cysts and polyps)</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Skin cancer</p></td></tr><tr><td style="vertical-align:top"><p>Blood and Lymphatic System Disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Bone marrow failure, CD4 lymphocytes decreased, leukopenia, thrombocytopenia, platelet count decreased, anaemia</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Metabolism and Nutrition Disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Anorexia</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Tumour lysis syndrome</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric Disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hallucination, disorientation</p></td></tr><tr><td style="vertical-align:top"><p>Nervous System Disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Convulsion, dizziness, peripheral neuropathy<sup>1</sup>, somnolence, headache</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, Thoracic, and Mediastinal Disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Pulmonary fibrosis, pulmonary oedema, lung infiltration, dyspnoea</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal Disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Pancreatitis<sup>1</sup>, nausea, vomiting, diarrhoea, stomatitis, constipation, mucositis, stomach discomfort, dyspepsia, abdominal pain, melaena</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary Disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hepatotoxicity<sup>1</sup>, hepatic enzyme increased, cholestasis, hepatitis</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Skin and Subcutaneous Tissue Disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Cutaneous vasculitis, dermatomyositis, alopecia, rash maculo-papular, rash papular, skin exfoliation, skin atrophy, skin ulcer, erythema, skin hyperpigmentation, nail disorder</p></td></tr><tr><td style="vertical-align:top"><p>Not Known</p></td><td style="vertical-align:top"><p>Nail pigmentation</p></td></tr><tr><td style="vertical-align:top"><p>Renal and Urinary Disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Dysuria, blood creatinine increased, blood urea increased, blood uric acid increased</p></td></tr><tr><td style="vertical-align:top"><p>General Disorders and Administration Site Conditions</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Pyrexia, asthenia, chills, malaise</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>azoospermia, oligospermia</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><sup>1</sup>&nbsp;Fatal and non-fatal pancreatitis and hepatotoxicity and severe peripheral neuropathy have been reported in HIV-infected patients who received hydroxyurea in combination with antiretroviral agents, in particular didanosine plus stavudine.</p></td></tr></tbody></table><p><u>Reporting of suspected adverse reactions</u><br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Immediate treatment consists of gastric lavage, followed by supportive therapy for the cardiorespiratory systems if required. In the long term, careful monitoring of the haemopoietic system is essential and, if necessary, blood should be transfused.</p><p>Acute mucocutaneous toxicity has been reported in patients receiving hydroxyurea at a dosage several times greater than that recommended. Soreness, violet erythema, oedema on palms and foot soles followed by scaling of hands and feet, intense generalised hyperpigmentation of skin, and severe acute stomatitis were observed.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: other antineoplastic agents.</p><p>ATC Code: L01XX05</p><p>Hydroxyurea is an orally active antineoplastic agent. Although the mechanism of action has not yet been clearly defined, hydroxyurea appears to act by interfering with synthesis of DNA.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After oral administration hydroxyurea is readily absorbed from the gastrointestinal tract. Peak plasma concentrations are reached in 2 hours; by 24 hours the serum concentrations are virtually zero. Approximately 80% of an oral or intravenous dose of 7 to 30 mg/kg may be recovered from the urine within 12 hours. Hydroxyurea crosses the blood-brain barrier. Hydroxyurea is well distributed throughout the body.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydroxyurea is unequivocally genotoxic and a presumed transpecies carcinogen which implies a carcinogenic risk to humans.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-&nbsp;&nbsp;&nbsp; Lactose monohydrate<br />-&nbsp;&nbsp;&nbsp; Citric acid<br />-&nbsp;&nbsp;&nbsp; Di-sodium hydrogen phosphate<br />-&nbsp;&nbsp;&nbsp; Magnesium stearate</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p><p>Store in the original package in order to protect from moisture.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PVC/Aclar-aluminum blisters</p><p>Pack size: 30 Hard Capsules.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cureaml is cytotoxic medication.</p><p>In healthcare settings, use designated area for medication storage and restrict access to only authorized personal.</p><p>People who are not taking Cureaml should not be exposed to it. To decrease the risk of exposure, wear disposable gloves when handling Cureaml. Anyone handling Cureaml should wash their hands before and after contact with the capsules. If the powder is spilled, it should be immediately wiped with a damp disposable towel and discarded in a closed container, such as a plastic bag, as should the empty capsules. Cureaml should be kept away from children. Pregnant women should not handle Cureaml.</p><p>To minimise the risk of dermal exposure, always wear chemotherapy impervious gloves and sleeve covers when handling capsules containing Cureaml. This includes all handling activities in clinical settings, pharmacies, storerooms and home healthcare settings, including during unpacking and inspection, transport within a facility, and dose preparation and administration. Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>For transportation of intact capsule within the facility, wear single chemotherapy gloves and place in double bag or in a sealed container. &nbsp;</p><p>Caution should be observed in handling open capsule; wear double chemotherapy gloves and place in double bag or in a sealed container. Avoid direct contact with skin or mucous membranes. If such contact occurs, wash thoroughly with soap and water, rinse eyes thoroughly with sterile water, or plain water if sterile water is unavailable.</p><p>When manipulations are necessary such as compounding, crushing, cutting, or splitting; should be performed within a ventilated engineering enclosure and/ or augment the control of generated aerosols using supplementary controls such as glove bags or pill pouches that contain the hazardous drug during and after the crushing process. &nbsp;</p><p>Wear double chemotherapy gloves, protective gown and sleeve covers. Add eye/face protection and respiratory protection [N95] if compounding is done outside of the ventilated engineering control. Hair and shoe covers should be worn. &nbsp;</p><p>When clinically appropriate, add liquid or moist products to crushed hazardous drug product as soon as possible after crushing, to avoid the potential of subsequent aerosol dissemination.</p><p>For medication administration, wear single chemotherapy gloves with intact and coated capsules and double chemotherapy gloves with opened or crushed capsules. Add eye and face protection if there is the potential to contact vomit or if patient may resist or is pre-disposed to spitting out.</p><p>Personnel who are pregnant should avoid handling Cureaml capsules.</p><p><strong>Disposal:</strong></p><ul><li>Wear double chemotherapy gloves and protective gown for any disposal or cleaning activity of medication contaminated waste.</li><li>Avoid creating dusts. Place in sealed bags for disposal. Use caution when closing bags as pushing waste down may force hazardous drug dusts up into the user&rsquo;s face.</li><li>For disposal of drugs and metabolites in body fluids, wear chemotherapy gloves and protective gown. Fold soft materials (sheets, hygiene care products) inward to prevent leakage and place in sealed bags.</li><li>In case of spill, limit access to area, use wet wiping method (absorbent pads for liquid spills). Place in sealed bags for disposal. Disinfection, deactivation or decontamination agents may be necessary.</li><li>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al-Kharj Road 
P.O. Box 106229
Riyadh 11666, Saudi Arabia
Tel: + (966-11) 8107023, + (966-11) 2142472
Fax: + (966-11) 2078170
e-mail: SAPV@hikma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 October 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>